ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC). [electronic resource]
Producer: 20140414Description: e72829 p. digitalISSN:- 1932-6203
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.